

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.47905565 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.47905565 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.21943528 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.21943528 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.75413806 |
| 6 | glyoxylate metabolic process (GO:0046487) | 5.43200957 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.16399729 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.16399729 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.16399729 |
| 10 | NADH metabolic process (GO:0006734) | 5.07225584 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.06563436 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.00768278 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 4.91747331 |
| 14 | tryptophan metabolic process (GO:0006568) | 4.91561038 |
| 15 | lysine catabolic process (GO:0006554) | 4.87856255 |
| 16 | lysine metabolic process (GO:0006553) | 4.87856255 |
| 17 | bile acid biosynthetic process (GO:0006699) | 4.83263199 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.78617556 |
| 19 | regulation of triglyceride catabolic process (GO:0010896) | 4.77678632 |
| 20 | branched-chain amino acid catabolic process (GO:0009083) | 4.74044801 |
| 21 | * fatty acid beta-oxidation (GO:0006635) | 4.69401918 |
| 22 | amino-acid betaine metabolic process (GO:0006577) | 4.62123834 |
| 23 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.58179795 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 4.58117676 |
| 25 | cysteine metabolic process (GO:0006534) | 4.57857110 |
| 26 | short-chain fatty acid metabolic process (GO:0046459) | 4.48892724 |
| 27 | acetyl-CoA metabolic process (GO:0006084) | 4.48325419 |
| 28 | * fatty acid oxidation (GO:0019395) | 4.39638234 |
| 29 | cellular ketone body metabolic process (GO:0046950) | 4.37800116 |
| 30 | * lipid oxidation (GO:0034440) | 4.32665875 |
| 31 | valine metabolic process (GO:0006573) | 4.32524268 |
| 32 | * fatty acid catabolic process (GO:0009062) | 4.31829244 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.29599361 |
| 34 | alpha-amino acid catabolic process (GO:1901606) | 4.28683872 |
| 35 | branched-chain amino acid metabolic process (GO:0009081) | 4.27657735 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 4.26299074 |
| 37 | urea metabolic process (GO:0019627) | 4.25693873 |
| 38 | urea cycle (GO:0000050) | 4.25693873 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 4.24175033 |
| 40 | oxaloacetate metabolic process (GO:0006107) | 4.21659411 |
| 41 | epoxygenase P450 pathway (GO:0019373) | 4.20885221 |
| 42 | complement activation, alternative pathway (GO:0006957) | 4.16907839 |
| 43 | regulation of sequestering of triglyceride (GO:0010889) | 4.16333819 |
| 44 | biotin metabolic process (GO:0006768) | 4.16287327 |
| 45 | fatty acid transmembrane transport (GO:1902001) | 4.12709925 |
| 46 | ethanol oxidation (GO:0006069) | 4.11871412 |
| 47 | * monocarboxylic acid catabolic process (GO:0072329) | 4.11460500 |
| 48 | high-density lipoprotein particle remodeling (GO:0034375) | 4.09648998 |
| 49 | tyrosine metabolic process (GO:0006570) | 4.09576213 |
| 50 | bile acid metabolic process (GO:0008206) | 4.08822835 |
| 51 | aspartate family amino acid catabolic process (GO:0009068) | 4.05873650 |
| 52 | 2-oxoglutarate metabolic process (GO:0006103) | 4.05258882 |
| 53 | cellular amino acid catabolic process (GO:0009063) | 4.05037394 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.04279981 |
| 55 | triglyceride homeostasis (GO:0070328) | 4.04279981 |
| 56 | nitrogen cycle metabolic process (GO:0071941) | 4.01866563 |
| 57 | carnitine metabolic process (GO:0009437) | 3.99510938 |
| 58 | coenzyme catabolic process (GO:0009109) | 3.98190924 |
| 59 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.97283750 |
| 60 | protein carboxylation (GO:0018214) | 3.97283750 |
| 61 | * carboxylic acid catabolic process (GO:0046395) | 3.93805682 |
| 62 | * organic acid catabolic process (GO:0016054) | 3.93805682 |
| 63 | regulation of fibrinolysis (GO:0051917) | 3.92725530 |
| 64 | carnitine shuttle (GO:0006853) | 3.90659593 |
| 65 | ATP synthesis coupled proton transport (GO:0015986) | 3.90139956 |
| 66 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.90139956 |
| 67 | cellular biogenic amine catabolic process (GO:0042402) | 3.88317157 |
| 68 | amine catabolic process (GO:0009310) | 3.88317157 |
| 69 | regulation of protein activation cascade (GO:2000257) | 3.88242720 |
| 70 | plasma lipoprotein particle clearance (GO:0034381) | 3.87165250 |
| 71 | negative regulation of fibrinolysis (GO:0051918) | 3.82395591 |
| 72 | regulation of cholesterol esterification (GO:0010872) | 3.82133745 |
| 73 | tricarboxylic acid cycle (GO:0006099) | 3.81054467 |
| 74 | plasma lipoprotein particle remodeling (GO:0034369) | 3.78800587 |
| 75 | protein-lipid complex remodeling (GO:0034368) | 3.78800587 |
| 76 | macromolecular complex remodeling (GO:0034367) | 3.78800587 |
| 77 | exogenous drug catabolic process (GO:0042738) | 3.78798738 |
| 78 | ketone body metabolic process (GO:1902224) | 3.78665496 |
| 79 | negative regulation of lipase activity (GO:0060192) | 3.76554580 |
| 80 | indolalkylamine metabolic process (GO:0006586) | 3.75808010 |
| 81 | L-serine metabolic process (GO:0006563) | 3.72301676 |
| 82 | aldehyde catabolic process (GO:0046185) | 3.71612923 |
| 83 | reverse cholesterol transport (GO:0043691) | 3.67109542 |
| 84 | respiratory electron transport chain (GO:0022904) | 3.63663297 |
| 85 | regulation of complement activation (GO:0030449) | 3.62211700 |
| 86 | benzene-containing compound metabolic process (GO:0042537) | 3.58838691 |
| 87 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.58771755 |
| 88 | cellular glucuronidation (GO:0052695) | 3.58389068 |
| 89 | drug catabolic process (GO:0042737) | 3.57297358 |
| 90 | phospholipid homeostasis (GO:0055091) | 3.55688606 |
| 91 | cellular modified amino acid catabolic process (GO:0042219) | 3.55079315 |
| 92 | electron transport chain (GO:0022900) | 3.53832473 |
| 93 | acyl-CoA metabolic process (GO:0006637) | 3.52825679 |
| 94 | thioester metabolic process (GO:0035383) | 3.52825679 |
| 95 | glutamate metabolic process (GO:0006536) | 3.52584499 |
| 96 | polyketide metabolic process (GO:0030638) | 3.52303208 |
| 97 | doxorubicin metabolic process (GO:0044598) | 3.52303208 |
| 98 | daunorubicin metabolic process (GO:0044597) | 3.52303208 |
| 99 | protein maturation by protein folding (GO:0022417) | 3.51521418 |
| 100 | serine family amino acid metabolic process (GO:0009069) | 3.51037205 |
| 101 | omega-hydroxylase P450 pathway (GO:0097267) | 3.50429025 |
| 102 | positive regulation of lipid catabolic process (GO:0050996) | 3.45295621 |
| 103 | phospholipid efflux (GO:0033700) | 3.44956675 |
| 104 | gluconeogenesis (GO:0006094) | 3.44328711 |
| 105 | proteasome assembly (GO:0043248) | 3.42782613 |
| 106 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.41448047 |
| 107 | positive regulation of fatty acid oxidation (GO:0046321) | 3.39135007 |
| 108 | glycine metabolic process (GO:0006544) | 3.38779902 |
| 109 | uronic acid metabolic process (GO:0006063) | 3.37550393 |
| 110 | glucuronate metabolic process (GO:0019585) | 3.37550393 |
| 111 | regulation of cholesterol metabolic process (GO:0090181) | 3.36961294 |
| 112 | very long-chain fatty acid metabolic process (GO:0000038) | 3.33068462 |
| 113 | oxidative phosphorylation (GO:0006119) | 3.32720532 |
| 114 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.32444869 |
| 115 | imidazole-containing compound metabolic process (GO:0052803) | 3.32160810 |
| 116 | serine family amino acid biosynthetic process (GO:0009070) | 3.31747924 |
| 117 | ethanol metabolic process (GO:0006067) | 3.31082219 |
| 118 | * small molecule catabolic process (GO:0044282) | 3.30859856 |
| 119 | monosaccharide biosynthetic process (GO:0046364) | 3.30562761 |
| 120 | hexose biosynthetic process (GO:0019319) | 3.28420395 |
| 121 | low-density lipoprotein particle remodeling (GO:0034374) | 3.27326876 |
| 122 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.26147862 |
| 123 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.26147862 |
| 124 | regulation of mitochondrial translation (GO:0070129) | 3.25607454 |
| 125 | drug metabolic process (GO:0017144) | 3.25059831 |
| 126 | chaperone-mediated protein transport (GO:0072321) | 3.20495111 |
| 127 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.17008643 |
| 128 | proline biosynthetic process (GO:0006561) | 3.16726221 |
| 129 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.16638109 |
| 130 | proline metabolic process (GO:0006560) | 3.11192536 |
| 131 | fibrinolysis (GO:0042730) | 3.08346296 |
| 132 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.02852561 |
| 133 | fructose metabolic process (GO:0006000) | 3.01382801 |
| 134 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.97446185 |
| 135 | primary alcohol catabolic process (GO:0034310) | 2.95888792 |
| 136 | cellular aldehyde metabolic process (GO:0006081) | 2.88543462 |
| 137 | xenobiotic catabolic process (GO:0042178) | 2.87051603 |
| 138 | amino acid salvage (GO:0043102) | 2.83648642 |
| 139 | L-methionine salvage (GO:0071267) | 2.83648642 |
| 140 | L-methionine biosynthetic process (GO:0071265) | 2.83648642 |
| 141 | arginine metabolic process (GO:0006525) | 2.80214549 |
| 142 | phenylpropanoid metabolic process (GO:0009698) | 2.78510468 |
| 143 | negative regulation of ligase activity (GO:0051352) | 2.77036780 |
| 144 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.77036780 |
| 145 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.75832429 |
| 146 | quinone metabolic process (GO:1901661) | 2.73158045 |
| 147 | tricarboxylic acid metabolic process (GO:0072350) | 2.71616571 |
| 148 | blood coagulation, intrinsic pathway (GO:0007597) | 2.70967320 |
| 149 | NADPH regeneration (GO:0006740) | 2.70069179 |
| 150 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.70068734 |
| 151 | aerobic respiration (GO:0009060) | 2.68842702 |
| 152 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.59666882 |
| 153 | ribosomal small subunit assembly (GO:0000028) | 2.59505394 |
| 154 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.59460813 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.76333880 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.43987559 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.84171236 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.93187108 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.82656590 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.44247889 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.48704154 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.24357891 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.66591658 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.61035256 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.50766895 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.29018106 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.26303723 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.24551302 |
| 15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.03835126 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.95903480 |
| 17 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.92576300 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.75459958 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.75314870 |
| 20 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.71753713 |
| 21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.70501184 |
| 22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.41421923 |
| 23 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.28935087 |
| 24 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.23381707 |
| 25 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.22266215 |
| 26 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.18462028 |
| 27 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.13715528 |
| 28 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.09128427 |
| 29 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.04782255 |
| 30 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.00108822 |
| 31 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.99041925 |
| 32 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.91715181 |
| 33 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.90607833 |
| 34 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.87525629 |
| 35 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.82798590 |
| 36 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.71219885 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.70902340 |
| 38 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.70880136 |
| 39 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.70178579 |
| 40 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.64805414 |
| 41 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.63322850 |
| 42 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.57543723 |
| 43 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.55935907 |
| 44 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.52894714 |
| 45 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.52329193 |
| 46 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.47934929 |
| 47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.47684406 |
| 48 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.47633121 |
| 49 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.45872908 |
| 50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44521120 |
| 51 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.43433463 |
| 52 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.42297147 |
| 53 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.39967140 |
| 54 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.39186950 |
| 55 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.36148269 |
| 56 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.35019689 |
| 57 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.32330061 |
| 58 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.31418875 |
| 59 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.30511265 |
| 60 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.29601278 |
| 61 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.29492605 |
| 62 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.28548059 |
| 63 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.27970723 |
| 64 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27839197 |
| 65 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26077501 |
| 66 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.25509616 |
| 67 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.24964947 |
| 68 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.24745016 |
| 69 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.24353599 |
| 70 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.24075945 |
| 71 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.22772579 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17272586 |
| 73 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.12868500 |
| 74 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.10982231 |
| 75 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.09648474 |
| 76 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09332462 |
| 77 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08369194 |
| 78 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.08100001 |
| 79 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.08023911 |
| 80 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07354528 |
| 81 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.05238518 |
| 82 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.05174213 |
| 83 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.04423908 |
| 84 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02408988 |
| 85 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.02119932 |
| 86 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.01941779 |
| 87 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.01410327 |
| 88 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.00055196 |
| 89 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.99761573 |
| 90 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99155048 |
| 91 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99094370 |
| 92 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98393425 |
| 93 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.97925296 |
| 94 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.97859860 |
| 95 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.95521696 |
| 96 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.95442203 |
| 97 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.95241562 |
| 98 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.95138659 |
| 99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94355039 |
| 100 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.94093493 |
| 101 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.93377827 |
| 102 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92870191 |
| 103 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.92377206 |
| 104 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.91681329 |
| 105 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.91644599 |
| 106 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.91352969 |
| 107 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.90724040 |
| 108 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.90658625 |
| 109 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90093429 |
| 110 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.89191206 |
| 111 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.88785284 |
| 112 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.88731140 |
| 113 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.88712818 |
| 114 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.88526502 |
| 115 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.87937154 |
| 116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87197965 |
| 117 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.87022470 |
| 118 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.86975783 |
| 119 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.84639268 |
| 120 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.84497488 |
| 121 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84292079 |
| 122 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.82933760 |
| 123 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.81232244 |
| 124 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.81232244 |
| 125 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.80455713 |
| 126 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.80424120 |
| 127 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.78793901 |
| 128 | AR_20517297_ChIP-Seq_VCAP_Human | 0.77632525 |
| 129 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.77009896 |
| 130 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.76866453 |
| 131 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.76273912 |
| 132 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76260053 |
| 133 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.75234440 |
| 134 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.74832842 |
| 135 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.74702248 |
| 136 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.73584938 |
| 137 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.73240650 |
| 138 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72358066 |
| 139 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72358066 |
| 140 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.71326927 |
| 141 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.70509428 |
| 142 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.69913485 |
| 143 | CBP_21632823_ChIP-Seq_H3396_Human | 0.69268002 |
| 144 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.68998428 |
| 145 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68813255 |
| 146 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.68297705 |
| 147 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.67881550 |
| 148 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.67406364 |
| 149 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.67270066 |
| 150 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.66193400 |
| 151 | VDR_22108803_ChIP-Seq_LS180_Human | 0.64390506 |
| 152 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.63920573 |
| 153 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.62689989 |
| 154 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.62608057 |
| 155 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.61563691 |
| 156 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.61289066 |
| 157 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.61187256 |
| 158 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.60953389 |
| 159 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.60117148 |
| 160 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.59537007 |
| 161 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.59222202 |
| 162 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.57933148 |
| 163 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.57932962 |
| 164 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.57318318 |
| 165 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.56289756 |
| 166 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.56123860 |
| 167 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.55812888 |
| 168 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.55752038 |
| 169 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55086801 |
| 170 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.54615805 |
| 171 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.53929400 |
| 172 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.53854079 |
| 173 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.53320679 |
| 174 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.52322995 |
| 175 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.52110597 |
| 176 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.51977280 |
| 177 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.51713462 |
| 178 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.51394538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.74721867 |
| 2 | MP0005360_urolithiasis | 6.39781221 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.46546990 |
| 4 | MP0005365_abnormal_bile_salt | 5.29979794 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.26734054 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.83332774 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.19310133 |
| 8 | MP0003252_abnormal_bile_duct | 3.07551788 |
| 9 | MP0005332_abnormal_amino_acid | 2.93633366 |
| 10 | MP0003195_calcinosis | 2.88871299 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.79314795 |
| 12 | MP0005083_abnormal_biliary_tract | 2.73383016 |
| 13 | MP0005670_abnormal_white_adipose | 2.63802686 |
| 14 | MP0005451_abnormal_body_composition | 2.34797392 |
| 15 | MP0009840_abnormal_foam_cell | 2.33161980 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.27640426 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.20882611 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.16868442 |
| 19 | MP0009379_abnormal_foot_pigmentation | 2.01850892 |
| 20 | MP0004130_abnormal_muscle_cell | 1.95709877 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.92658799 |
| 22 | MP0010030_abnormal_orbit_morphology | 1.83868069 |
| 23 | MP0005666_abnormal_adipose_tissue | 1.81775837 |
| 24 | MP0000609_abnormal_liver_physiology | 1.79589228 |
| 25 | MP0006036_abnormal_mitochondrial_physio | 1.74124820 |
| 26 | MP0003693_abnormal_embryo_hatching | 1.70933325 |
| 27 | MP0003011_delayed_dark_adaptation | 1.70461044 |
| 28 | MP0003646_muscle_fatigue | 1.70408556 |
| 29 | MP0003186_abnormal_redox_activity | 1.68349220 |
| 30 | MP0005319_abnormal_enzyme/_coenzyme | 1.67586014 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58325397 |
| 32 | MP0001764_abnormal_homeostasis | 1.56309828 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.55210482 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 1.46374748 |
| 35 | MP0005330_cardiomyopathy | 1.43146272 |
| 36 | MP0009697_abnormal_copulation | 1.42512804 |
| 37 | MP0002971_abnormal_brown_adipose | 1.41895443 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.38894537 |
| 39 | MP0003868_abnormal_feces_composition | 1.32338206 |
| 40 | MP0004957_abnormal_blastocyst_morpholog | 1.31226406 |
| 41 | MP0003941_abnormal_skin_development | 1.27362704 |
| 42 | MP0001661_extended_life_span | 1.25933171 |
| 43 | MP0000566_synostosis | 1.23159084 |
| 44 | MP0004215_abnormal_myocardial_fiber | 1.19975807 |
| 45 | MP0005647_abnormal_sex_gland | 1.16881799 |
| 46 | MP0008932_abnormal_embryonic_tissue | 1.10823582 |
| 47 | MP0005535_abnormal_body_temperature | 1.09478341 |
| 48 | MP0003123_paternal_imprinting | 1.07807594 |
| 49 | MP0002876_abnormal_thyroid_physiology | 1.07691276 |
| 50 | MP0010234_abnormal_vibrissa_follicle | 1.07019914 |
| 51 | MP0000747_muscle_weakness | 1.06461172 |
| 52 | MP0005334_abnormal_fat_pad | 1.04318204 |
| 53 | MP0004043_abnormal_pH_regulation | 1.03752588 |
| 54 | MP0004036_abnormal_muscle_relaxation | 1.02615162 |
| 55 | MP0004185_abnormal_adipocyte_glucose | 1.02461791 |
| 56 | MP0000751_myopathy | 1.00404902 |
| 57 | MP0004084_abnormal_cardiac_muscle | 1.00314277 |
| 58 | MP0001881_abnormal_mammary_gland | 0.97833825 |
| 59 | MP0002254_reproductive_system_inflammat | 0.97549560 |
| 60 | MP0004381_abnormal_hair_follicle | 0.97142745 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 0.92616578 |
| 62 | MP0009763_increased_sensitivity_to | 0.92582160 |
| 63 | MP0005375_adipose_tissue_phenotype | 0.91263904 |
| 64 | MP0006035_abnormal_mitochondrial_morpho | 0.90727398 |
| 65 | MP0001727_abnormal_embryo_implantation | 0.89992134 |
| 66 | MP0002078_abnormal_glucose_homeostasis | 0.89705999 |
| 67 | MP0003690_abnormal_glial_cell | 0.86803692 |
| 68 | MP0003315_abnormal_perineum_morphology | 0.85977706 |
| 69 | MP0000749_muscle_degeneration | 0.85637464 |
| 70 | MP0004233_abnormal_muscle_weight | 0.84782729 |
| 71 | MP0006138_congestive_heart_failure | 0.84433052 |
| 72 | MP0002972_abnormal_cardiac_muscle | 0.84045105 |
| 73 | MP0002938_white_spotting | 0.83984575 |
| 74 | MP0005266_abnormal_metabolism | 0.83162823 |
| 75 | MP0009672_abnormal_birth_weight | 0.82692378 |
| 76 | MP0002132_abnormal_respiratory_system | 0.82627490 |
| 77 | MP0009764_decreased_sensitivity_to | 0.82503405 |
| 78 | MP0001544_abnormal_cardiovascular_syste | 0.82292766 |
| 79 | MP0005385_cardiovascular_system_phenoty | 0.82292766 |
| 80 | MP0000538_abnormal_urinary_bladder | 0.80778210 |
| 81 | MP0009053_abnormal_anal_canal | 0.79705286 |
| 82 | MP0000598_abnormal_liver_morphology | 0.79450909 |
| 83 | MP0005376_homeostasis/metabolism_phenot | 0.79417997 |
| 84 | MP0005620_abnormal_muscle_contractility | 0.78816927 |
| 85 | MP0009642_abnormal_blood_homeostasis | 0.77916050 |
| 86 | MP0008058_abnormal_DNA_repair | 0.76538526 |
| 87 | MP0008775_abnormal_heart_ventricle | 0.75859801 |
| 88 | MP0003137_abnormal_impulse_conducting | 0.74913327 |
| 89 | MP0009115_abnormal_fat_cell | 0.74242504 |
| 90 | MP0000230_abnormal_systemic_arterial | 0.74070285 |
| 91 | MP0005448_abnormal_energy_balance | 0.73040267 |
| 92 | MP0001756_abnormal_urination | 0.72360847 |
| 93 | MP0010368_abnormal_lymphatic_system | 0.72119667 |
| 94 | MP0000358_abnormal_cell_content/ | 0.71711520 |
| 95 | MP0002090_abnormal_vision | 0.71506844 |
| 96 | MP0004147_increased_porphyrin_level | 0.71302651 |
| 97 | MP0002332_abnormal_exercise_endurance | 0.71203182 |
| 98 | MP0005408_hypopigmentation | 0.71165155 |
| 99 | MP0001529_abnormal_vocalization | 0.71091146 |
| 100 | MP0003111_abnormal_nucleus_morphology | 0.70913739 |
| 101 | MP0000537_abnormal_urethra_morphology | 0.70618449 |
| 102 | MP0003656_abnormal_erythrocyte_physiolo | 0.68618522 |
| 103 | MP0008007_abnormal_cellular_replicative | 0.68368220 |
| 104 | MP0005501_abnormal_skin_physiology | 0.68119480 |
| 105 | MP0004087_abnormal_muscle_fiber | 0.66978895 |
| 106 | MP0008789_abnormal_olfactory_epithelium | 0.66547931 |
| 107 | MP0003724_increased_susceptibility_to | 0.65570359 |
| 108 | MP0003077_abnormal_cell_cycle | 0.65452055 |
| 109 | MP0002269_muscular_atrophy | 0.64836760 |
| 110 | MP0008872_abnormal_physiological_respon | 0.64422897 |
| 111 | MP0001905_abnormal_dopamine_level | 0.64296742 |
| 112 | MP0003950_abnormal_plasma_membrane | 0.64017239 |
| 113 | MP0005084_abnormal_gallbladder_morpholo | 0.63831446 |
| 114 | MP0000750_abnormal_muscle_regeneration | 0.63731096 |
| 115 | MP0003786_premature_aging | 0.63587777 |
| 116 | MP0000003_abnormal_adipose_tissue | 0.63307312 |
| 117 | MP0008469_abnormal_protein_level | 0.62794973 |
| 118 | MP0000467_abnormal_esophagus_morphology | 0.61953820 |
| 119 | MP0000372_irregular_coat_pigmentation | 0.60488065 |
| 120 | MP0002970_abnormal_white_adipose | 0.60404596 |
| 121 | MP0000759_abnormal_skeletal_muscle | 0.60172175 |
| 122 | MP0000579_abnormal_nail_morphology | 0.59074162 |
| 123 | MP0004145_abnormal_muscle_electrophysio | 0.58498174 |
| 124 | MP0005165_increased_susceptibility_to | 0.57339502 |
| 125 | MP0010630_abnormal_cardiac_muscle | 0.57126985 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.56672422 |
| 127 | MP0002909_abnormal_adrenal_gland | 0.54995692 |
| 128 | MP0001730_embryonic_growth_arrest | 0.54904567 |
| 129 | MP0000604_amyloidosis | 0.53707885 |
| 130 | MP0004272_abnormal_basement_membrane | 0.52970371 |
| 131 | MP0003959_abnormal_lean_body | 0.52772085 |
| 132 | MP0003221_abnormal_cardiomyocyte_apopto | 0.52572378 |
| 133 | MP0005395_other_phenotype | 0.51781535 |
| 134 | MP0003953_abnormal_hormone_level | 0.50797006 |
| 135 | MP0003718_maternal_effect | 0.49994771 |
| 136 | MP0005452_abnormal_adipose_tissue | 0.49104312 |
| 137 | MP0002136_abnormal_kidney_physiology | 0.49080741 |
| 138 | MP0009384_cardiac_valve_regurgitation | 0.47727966 |
| 139 | MP0004085_abnormal_heartbeat | 0.46983124 |
| 140 | MP0002796_impaired_skin_barrier | 0.43952330 |
| 141 | MP0005220_abnormal_exocrine_pancreas | 0.42550039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.56861354 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.44475667 |
| 3 | Hyperglycinuria (HP:0003108) | 5.16811774 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.83615710 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 4.81553920 |
| 6 | Abnormality of glycine metabolism (HP:0010895) | 4.80299415 |
| 7 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.80299415 |
| 8 | Xanthomatosis (HP:0000991) | 4.79773627 |
| 9 | Hyperammonemia (HP:0001987) | 4.70776189 |
| 10 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.67735644 |
| 11 | Hypoglycemic coma (HP:0001325) | 4.62775663 |
| 12 | Ketosis (HP:0001946) | 4.61091909 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 4.52088962 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.50497580 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 4.30898704 |
| 16 | Hyperglycinemia (HP:0002154) | 4.25473790 |
| 17 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 4.13116483 |
| 18 | Dicarboxylic aciduria (HP:0003215) | 4.13116483 |
| 19 | Ketoacidosis (HP:0001993) | 3.97801970 |
| 20 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.92120687 |
| 21 | Cerebral edema (HP:0002181) | 3.90754739 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 3.79176157 |
| 23 | Hypolipoproteinemia (HP:0010981) | 3.79048262 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.75571545 |
| 25 | Complement deficiency (HP:0004431) | 3.74292498 |
| 26 | Joint hemorrhage (HP:0005261) | 3.67120414 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.63587543 |
| 28 | Epidermoid cyst (HP:0200040) | 3.62135276 |
| 29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.61675903 |
| 30 | Abnormality of methionine metabolism (HP:0010901) | 3.49682407 |
| 31 | Lethargy (HP:0001254) | 3.36310531 |
| 32 | Generalized aminoaciduria (HP:0002909) | 3.33394652 |
| 33 | Renal cortical cysts (HP:0000803) | 3.31848431 |
| 34 | Hepatic necrosis (HP:0002605) | 3.29306654 |
| 35 | Reduced antithrombin III activity (HP:0001976) | 3.24882368 |
| 36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.23449068 |
| 37 | Metabolic acidosis (HP:0001942) | 3.21681082 |
| 38 | Abnormality of serum amino acid levels (HP:0003112) | 3.20657520 |
| 39 | Fat malabsorption (HP:0002630) | 3.08240335 |
| 40 | Proximal tubulopathy (HP:0000114) | 3.08053431 |
| 41 | Acute encephalopathy (HP:0006846) | 3.05046331 |
| 42 | Conjugated hyperbilirubinemia (HP:0002908) | 3.02561042 |
| 43 | Myoglobinuria (HP:0002913) | 3.01574853 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.97754420 |
| 45 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.93063996 |
| 46 | Cholecystitis (HP:0001082) | 2.92779057 |
| 47 | Abnormal gallbladder physiology (HP:0012438) | 2.92779057 |
| 48 | Abnormality of the common coagulation pathway (HP:0010990) | 2.89990685 |
| 49 | Delayed CNS myelination (HP:0002188) | 2.86270015 |
| 50 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.83543187 |
| 51 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.83543187 |
| 52 | Exercise intolerance (HP:0003546) | 2.81080836 |
| 53 | Increased hepatocellular lipid droplets (HP:0006565) | 2.75611359 |
| 54 | Renal Fanconi syndrome (HP:0001994) | 2.75399102 |
| 55 | Hypercholesterolemia (HP:0003124) | 2.75080920 |
| 56 | Vomiting (HP:0002013) | 2.72476997 |
| 57 | Abnormality of glycolysis (HP:0004366) | 2.71337267 |
| 58 | Increased serum pyruvate (HP:0003542) | 2.71337267 |
| 59 | Abnormality of nucleobase metabolism (HP:0010932) | 2.69645205 |
| 60 | Nausea (HP:0002018) | 2.67656231 |
| 61 | Rhabdomyolysis (HP:0003201) | 2.64515227 |
| 62 | Microvesicular hepatic steatosis (HP:0001414) | 2.62369519 |
| 63 | Increased serum lactate (HP:0002151) | 2.60342141 |
| 64 | Increased muscle lipid content (HP:0009058) | 2.59355360 |
| 65 | Abnormality of purine metabolism (HP:0004352) | 2.57935810 |
| 66 | Hyperbilirubinemia (HP:0002904) | 2.56883800 |
| 67 | Respiratory failure (HP:0002878) | 2.55336023 |
| 68 | Hyperphosphaturia (HP:0003109) | 2.54640822 |
| 69 | Abnormality of urine glucose concentration (HP:0011016) | 2.53569918 |
| 70 | Glycosuria (HP:0003076) | 2.53569918 |
| 71 | Abnormality of complement system (HP:0005339) | 2.53505872 |
| 72 | Abnormality of the intrinsic pathway (HP:0010989) | 2.51104239 |
| 73 | Steatorrhea (HP:0002570) | 2.44906192 |
| 74 | Hepatocellular necrosis (HP:0001404) | 2.44808876 |
| 75 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.43905932 |
| 76 | Acute necrotizing encephalopathy (HP:0006965) | 2.43259075 |
| 77 | Type I transferrin isoform profile (HP:0003642) | 2.37710667 |
| 78 | Ragged-red muscle fibers (HP:0003200) | 2.36338320 |
| 79 | Lactic acidosis (HP:0003128) | 2.34704640 |
| 80 | Vascular calcification (HP:0004934) | 2.34547668 |
| 81 | Skin nodule (HP:0200036) | 2.34011896 |
| 82 | Pancreatitis (HP:0001733) | 2.28809396 |
| 83 | Hypoglycemic seizures (HP:0002173) | 2.28552307 |
| 84 | CNS demyelination (HP:0007305) | 2.27073794 |
| 85 | Abnormality of proline metabolism (HP:0010907) | 2.22905800 |
| 86 | Hydroxyprolinuria (HP:0003080) | 2.22905800 |
| 87 | Gout (HP:0001997) | 2.21511373 |
| 88 | Methylmalonic aciduria (HP:0012120) | 2.20727060 |
| 89 | Enlarged kidneys (HP:0000105) | 2.20450150 |
| 90 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.19912612 |
| 91 | Palpitations (HP:0001962) | 2.12031492 |
| 92 | Macrocytic anemia (HP:0001972) | 2.11197363 |
| 93 | Hypertriglyceridemia (HP:0002155) | 2.08305700 |
| 94 | Multiple enchondromatosis (HP:0005701) | 2.08000759 |
| 95 | Ventricular tachycardia (HP:0004756) | 2.07938255 |
| 96 | Mitochondrial inheritance (HP:0001427) | 2.07823674 |
| 97 | Opisthotonus (HP:0002179) | 2.07354972 |
| 98 | Increased purine levels (HP:0004368) | 2.07242347 |
| 99 | Hyperuricemia (HP:0002149) | 2.07242347 |
| 100 | Cerebral palsy (HP:0100021) | 2.06715330 |
| 101 | Increased CSF lactate (HP:0002490) | 2.06164146 |
| 102 | Sudden death (HP:0001699) | 2.05545235 |
| 103 | Cardiovascular calcification (HP:0011915) | 2.05269516 |
| 104 | Abnormal gallbladder morphology (HP:0012437) | 2.05103271 |
| 105 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.04103300 |
| 106 | Right ventricular cardiomyopathy (HP:0011663) | 2.04008448 |
| 107 | Nemaline bodies (HP:0003798) | 2.03933838 |
| 108 | Exercise-induced myalgia (HP:0003738) | 2.03928136 |
| 109 | Cholelithiasis (HP:0001081) | 2.03233708 |
| 110 | Progressive macrocephaly (HP:0004481) | 2.01376641 |
| 111 | Methylmalonic acidemia (HP:0002912) | 2.00323644 |
| 112 | Myocardial infarction (HP:0001658) | 1.99823950 |
| 113 | Abnormal urine phosphate concentration (HP:0012599) | 1.99779676 |
| 114 | Increased intramyocellular lipid droplets (HP:0012240) | 1.97314516 |
| 115 | Respiratory distress (HP:0002098) | 1.96842765 |
| 116 | Brushfield spots (HP:0001088) | 1.95074544 |
| 117 | Hepatocellular carcinoma (HP:0001402) | 1.93811924 |
| 118 | Testicular atrophy (HP:0000029) | 1.92477699 |
| 119 | Lipid accumulation in hepatocytes (HP:0006561) | 1.88227611 |
| 120 | Hypophosphatemic rickets (HP:0004912) | 1.86337834 |
| 121 | Neonatal onset (HP:0003623) | 1.86033778 |
| 122 | Megaloblastic anemia (HP:0001889) | 1.85230520 |
| 123 | Renal tubular dysfunction (HP:0000124) | 1.84827198 |
| 124 | Glomerulonephritis (HP:0000099) | 1.84813462 |
| 125 | Elevated hepatic transaminases (HP:0002910) | 1.84487813 |
| 126 | Muscle fiber inclusion bodies (HP:0100299) | 1.83929895 |
| 127 | Progressive muscle weakness (HP:0003323) | 1.83832924 |
| 128 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.83485645 |
| 129 | Distal lower limb muscle weakness (HP:0009053) | 1.82772317 |
| 130 | Abnormality of vitamin metabolism (HP:0100508) | 1.82262175 |
| 131 | Exercise-induced muscle cramps (HP:0003710) | 1.80483610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.17508853 |
| 2 | VRK2 | 4.80977662 |
| 3 | BUB1 | 3.33088500 |
| 4 | INSRR | 3.23484399 |
| 5 | TESK1 | 3.21692126 |
| 6 | SIK1 | 3.04502936 |
| 7 | NEK1 | 2.74077551 |
| 8 | LIMK1 | 2.47855779 |
| 9 | OBSCN | 2.41742880 |
| 10 | PDK4 | 2.32024834 |
| 11 | PDK3 | 2.32024834 |
| 12 | LMTK2 | 2.28253420 |
| 13 | EPHA2 | 2.24482169 |
| 14 | MAP3K12 | 2.24313576 |
| 15 | TIE1 | 2.16779391 |
| 16 | MYLK | 2.15857495 |
| 17 | FGFR4 | 2.15304246 |
| 18 | STK16 | 2.02407290 |
| 19 | PHKG2 | 1.90715910 |
| 20 | PHKG1 | 1.90715910 |
| 21 | NME1 | 1.82650575 |
| 22 | TESK2 | 1.80591136 |
| 23 | EIF2AK1 | 1.77997225 |
| 24 | MST1R | 1.77852241 |
| 25 | PRKAA2 | 1.75263631 |
| 26 | ARAF | 1.74676930 |
| 27 | CAMK1D | 1.74523707 |
| 28 | WNK4 | 1.72805085 |
| 29 | ERBB4 | 1.72758115 |
| 30 | PIM2 | 1.72096837 |
| 31 | STK38L | 1.70934547 |
| 32 | PDK2 | 1.68089315 |
| 33 | STK39 | 1.66980772 |
| 34 | TTN | 1.65921614 |
| 35 | PIK3CG | 1.64558525 |
| 36 | SMG1 | 1.64110575 |
| 37 | PAK4 | 1.63866949 |
| 38 | PINK1 | 1.61384047 |
| 39 | SCYL2 | 1.57252156 |
| 40 | PIK3CA | 1.52526120 |
| 41 | SRPK1 | 1.51392632 |
| 42 | IRAK3 | 1.50699889 |
| 43 | LATS1 | 1.49486204 |
| 44 | GRK7 | 1.47833583 |
| 45 | ERN1 | 1.45632088 |
| 46 | PKN1 | 1.42786815 |
| 47 | EIF2AK2 | 1.37930525 |
| 48 | PBK | 1.32637899 |
| 49 | TSSK6 | 1.30734485 |
| 50 | VRK1 | 1.29275562 |
| 51 | ILK | 1.27200813 |
| 52 | MUSK | 1.25904457 |
| 53 | DAPK1 | 1.24504338 |
| 54 | MST4 | 1.21190030 |
| 55 | ZAK | 1.17844373 |
| 56 | MAPKAPK3 | 1.17749249 |
| 57 | GRK1 | 1.14654080 |
| 58 | DAPK3 | 1.14077940 |
| 59 | OXSR1 | 1.11915969 |
| 60 | FGFR2 | 1.09652310 |
| 61 | MAPK12 | 1.08310825 |
| 62 | EPHB1 | 1.07907980 |
| 63 | CAMK1G | 1.07881649 |
| 64 | TAOK3 | 1.07232548 |
| 65 | FLT3 | 1.01728963 |
| 66 | MAPK11 | 1.00526041 |
| 67 | TAF1 | 0.99771542 |
| 68 | NEK9 | 0.97140176 |
| 69 | MAP3K7 | 0.94822996 |
| 70 | LRRK2 | 0.93123484 |
| 71 | BRSK1 | 0.89158190 |
| 72 | ABL2 | 0.88167030 |
| 73 | AURKA | 0.82985243 |
| 74 | RPS6KB2 | 0.82842908 |
| 75 | PRKAA1 | 0.82684092 |
| 76 | CDK8 | 0.81661270 |
| 77 | CSNK1G3 | 0.80149744 |
| 78 | CAMK2G | 0.78928375 |
| 79 | TRIM28 | 0.78680228 |
| 80 | AURKB | 0.78125076 |
| 81 | PLK3 | 0.78016535 |
| 82 | CASK | 0.76748095 |
| 83 | PLK1 | 0.76010456 |
| 84 | EIF2AK3 | 0.75644862 |
| 85 | MAP3K11 | 0.74424017 |
| 86 | WNK3 | 0.72125689 |
| 87 | CAMK2D | 0.70105148 |
| 88 | SGK223 | 0.69737422 |
| 89 | SGK494 | 0.69737422 |
| 90 | PRKD3 | 0.69521751 |
| 91 | CDK7 | 0.69007611 |
| 92 | CDC7 | 0.68547224 |
| 93 | PKN2 | 0.68263469 |
| 94 | MAP2K4 | 0.68092523 |
| 95 | MET | 0.68022698 |
| 96 | PRKACG | 0.67095793 |
| 97 | IRAK2 | 0.66734351 |
| 98 | KDR | 0.62382197 |
| 99 | STK24 | 0.61039108 |
| 100 | FRK | 0.60901664 |
| 101 | PRKCI | 0.57978484 |
| 102 | IRAK1 | 0.57692916 |
| 103 | BRAF | 0.57035189 |
| 104 | STK4 | 0.57015432 |
| 105 | MAPK15 | 0.55986304 |
| 106 | CSNK2A2 | 0.54320967 |
| 107 | MAPK7 | 0.54314452 |
| 108 | MAPK4 | 0.54239325 |
| 109 | DYRK2 | 0.54101703 |
| 110 | NUAK1 | 0.54002684 |
| 111 | PRKD1 | 0.53381329 |
| 112 | PAK1 | 0.53214896 |
| 113 | MAP2K3 | 0.53068728 |
| 114 | TGFBR2 | 0.52659282 |
| 115 | PRKACA | 0.52596809 |
| 116 | MAP3K14 | 0.51277730 |
| 117 | MAP4K2 | 0.51075016 |
| 118 | WEE1 | 0.50529941 |
| 119 | GSK3A | 0.50390898 |
| 120 | ADRBK2 | 0.50238575 |
| 121 | TAOK2 | 0.50015628 |
| 122 | CSNK2A1 | 0.49801990 |
| 123 | PRKCQ | 0.48965963 |
| 124 | BMPR1B | 0.46018901 |
| 125 | TYK2 | 0.44924511 |
| 126 | JAK1 | 0.44860764 |
| 127 | PDPK1 | 0.44342575 |
| 128 | MAP2K7 | 0.44052955 |
| 129 | PRKG2 | 0.43523669 |
| 130 | PTK2 | 0.43050190 |
| 131 | TRIB3 | 0.43048388 |
| 132 | ERBB2 | 0.43033196 |
| 133 | CSNK1G2 | 0.43031498 |
| 134 | EPHB2 | 0.42061486 |
| 135 | CAMK4 | 0.41804161 |
| 136 | SGK2 | 0.41473372 |
| 137 | MAP3K3 | 0.39889277 |
| 138 | CDK11A | 0.39594398 |
| 139 | EPHA3 | 0.39392059 |
| 140 | CSNK1A1L | 0.39184154 |
| 141 | CDK18 | 0.38949522 |
| 142 | PRKCE | 0.38576564 |
| 143 | CDK15 | 0.38178097 |
| 144 | CDK14 | 0.38118111 |
| 145 | CSNK1G1 | 0.37596778 |
| 146 | PRKACB | 0.37228168 |
| 147 | JAK2 | 0.37053535 |
| 148 | IGF1R | 0.36719018 |
| 149 | FER | 0.36169593 |
| 150 | CAMK2A | 0.35766205 |
| 151 | NME2 | 0.35716519 |
| 152 | MAP3K8 | 0.35170208 |
| 153 | PTK6 | 0.34947467 |
| 154 | PAK3 | 0.33280795 |
| 155 | TTK | 0.33255425 |
| 156 | LATS2 | 0.32856837 |
| 157 | MAP3K6 | 0.32027585 |
| 158 | MAPKAPK5 | 0.31928068 |
| 159 | PRKCZ | 0.31719996 |
| 160 | MAP2K6 | 0.30136953 |
| 161 | NEK6 | 0.29347461 |
| 162 | AKT2 | 0.29203372 |
| 163 | ATR | 0.27944209 |
| 164 | CHEK2 | 0.27926735 |
| 165 | CDK9 | 0.27242281 |
| 166 | MAP3K9 | 0.27217605 |
| 167 | TLK1 | 0.26162494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.33325813 |
| 2 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.17861549 |
| 3 | * Propanoate metabolism_Homo sapiens_hsa00640 | 3.07330501 |
| 4 | * Fatty acid degradation_Homo sapiens_hsa00071 | 3.04847658 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.68848243 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.60339488 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.56530255 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.53090867 |
| 9 | * Fatty acid metabolism_Homo sapiens_hsa01212 | 2.51812360 |
| 10 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.48262788 |
| 11 | Proteasome_Homo sapiens_hsa03050 | 2.48159564 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.44742755 |
| 13 | * Butanoate metabolism_Homo sapiens_hsa00650 | 2.33612754 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.32836588 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.29010720 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.25654467 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.22137855 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.20342610 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.15856041 |
| 20 | * Fatty acid elongation_Homo sapiens_hsa00062 | 2.13921250 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.07985196 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.98945910 |
| 23 | * beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.94202215 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.94032545 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.92403006 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.87589895 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.80062885 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78945502 |
| 29 | Ribosome_Homo sapiens_hsa03010 | 1.73882293 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.72889645 |
| 31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.72070836 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.63034698 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62428062 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.60251524 |
| 35 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.57452341 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.54193095 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.50836215 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37741632 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.34840245 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.29678357 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29079738 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.28782541 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.26493947 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.18870373 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18405616 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.18126522 |
| 47 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.17603388 |
| 48 | DNA replication_Homo sapiens_hsa03030 | 1.15251023 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13926550 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10667022 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07963984 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.07519166 |
| 53 | RNA polymerase_Homo sapiens_hsa03020 | 1.07415317 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.07184058 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 1.06187044 |
| 56 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.06042130 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 1.05296332 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00937408 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.95680646 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.94547037 |
| 61 | Base excision repair_Homo sapiens_hsa03410 | 0.93963180 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93148416 |
| 63 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.92476769 |
| 64 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.92371672 |
| 65 | Mismatch repair_Homo sapiens_hsa03430 | 0.91777059 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.89780869 |
| 67 | Parkinsons disease_Homo sapiens_hsa05012 | 0.87084849 |
| 68 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.84909845 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84529077 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.81905821 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80701174 |
| 72 | * Lysine degradation_Homo sapiens_hsa00310 | 0.77961613 |
| 73 | Protein export_Homo sapiens_hsa03060 | 0.76103160 |
| 74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73903920 |
| 75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73619875 |
| 76 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.69124682 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.68910379 |
| 78 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.61097151 |
| 79 | Alzheimers disease_Homo sapiens_hsa05010 | 0.58926349 |
| 80 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55157785 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54661373 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54085438 |
| 83 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.49317711 |
| 84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49094337 |
| 85 | Purine metabolism_Homo sapiens_hsa00230 | 0.48967957 |
| 86 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.43700619 |
| 87 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42153762 |
| 88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41236212 |
| 89 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.38622324 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.38221377 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36027558 |
| 92 | Spliceosome_Homo sapiens_hsa03040 | 0.34561803 |
| 93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.31950844 |
| 94 | Homologous recombination_Homo sapiens_hsa03440 | 0.28718080 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27683141 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25004820 |
| 97 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.24371669 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24317537 |
| 99 | RNA transport_Homo sapiens_hsa03013 | 0.22794177 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.21809550 |
| 101 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.19611875 |
| 102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19300825 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.16876688 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16094896 |
| 105 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.11833917 |
| 106 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.11271356 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.09316298 |
| 108 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.09165584 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.06497813 |
| 110 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1818120 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | -0.1680123 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1251109 |
| 113 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | -0.1246767 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0862405 |
| 115 | Prion diseases_Homo sapiens_hsa05020 | -0.0786373 |
| 116 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0638528 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0504293 |
| 118 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.0500842 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0437557 |
| 120 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | -0.0038210 |

